EUVIMEDEUVIMED entdecken
Crossref

Sitagliptin and Metformin in Fixed Dose Combination:  The Emerging Evidence of its Therapeutic Impact in Type 2 Diabetes

Baptist Gallwitz

Clinical Medicine Reviews in Vascular Health · 2010

DOI: 10.4137/cmrvh.s3372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine Reviews in Vascular Health, 2010. Verfasst von Baptist Gallwitz.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gallwitz, B. (2010). Sitagliptin and Metformin in Fixed Dose Combination: The Emerging Evidence of its Therapeutic Impact in Type 2 Diabetes. Clinical Medicine Reviews in Vascular Health. https://doi.org/10.4137/cmrvh.s3372

Vancouver

Gallwitz B. Sitagliptin and Metformin in Fixed Dose Combination: The Emerging Evidence of its Therapeutic Impact in Type 2 Diabetes. Clinical Medicine Reviews in Vascular Health. 2010. doi:10.4137/cmrvh.s3372

BibTeX
@article{Gallwitz2010,
  author = {Gallwitz, Baptist},
  title = {Sitagliptin and Metformin in Fixed Dose Combination: The Emerging Evidence of its Therapeutic Impact in Type 2 Diabetes},
  journal = {Clinical Medicine Reviews in Vascular Health},
  year = {2010},
  doi = {10.4137/cmrvh.s3372}
}
Kostenlos starten →